Henrik Birkedal, Merete Bilde, Tobias Weidner, Thomas Boesen, Rikke Louise Meyer, and Alexander Zelikin receive DKK 36 million in total from the Novo Nordisk Foundation for infrastructure for studying bone structure, studies in microbial aerosols, and the battle against antimicrobial resistance.